BSAC Spring Conference & AGM
Addressing the AMR burden in everyday practice
18-19 May 2023
QEII Conference Centre London & online
Mr Tom Monroe
CEO, Vaxxilon
Tom Monroe was one of the founders of Vaxxilon in 2015. Prior, he spent more than 20 years working in the biopharmaceutical industry for Syntex, Roche, and Actelion. He holds and SM in Finance from MIT with a focus on health care.
© 2023, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
53 Regent Place, Birmingham B1 3NJ
Registered Charity 1093118